Cancer/Tumor Profiling Market - Global Industry Analysis

Cancer/Tumor Profiling Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Category: Pharmaceutical Report Format : PDF Report Code: ZMR-1160 Status : Upcoming

Description

Global Cancer/Tumor Profiling Market: Overview

Cancer is a life-threatening disease differentiated by uncontrolled cell growth. It is mostly caused by environmental reasons that alter the gene encoding responsible for cell regulation. The consequential cell mutation results in abnormal cell growth that devastates the neighboring normal tissue and then extends the disease to very important organs. Cancer/tumor profiling is done to get knowledge about cancer profile & genomic alterations of a patient that help physicians to direct a patient with most suitable therapy. In addition, profiling also assists physicians to eliminate therapies that are doubtful to be doing well and hence, decreases the mistakes and trial procedures.

Report Scope:

Report Attribute Details
Base Year 2020
Historic Years 2016 - 2020
Forecast Years 2021 - 2028
Segments Covered By Product Type, By Application, and By End Use
Forecast Units Value (USD Billion), and Volume (Units)
Quantitative Units Revenue in USD million/billion and CAGR from 2021 to 2028
Regions Covered North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World
Countries Covered U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others
Number of Companies Covered 10 companies with scope for including additional 15 companies upon request
Report Coverage Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis.
Customization Scope Avail customized purchase options to meet your exact research needs.

Global Cancer/Tumor Profiling Market: Growth Factors           

The various factors responsible for the growth of global cancer/tumor profiling market include the growing digit of cancer incidences across the world, accessibility of expenditure for cancer research, huge capital funds, the growing usage of biomarkers, and low benefit ratio for biomarkers utilized in cancer/tumor. The growing need for point-of-care diagnostic tests and personalized medicine in cancer/tumor profiling are anticipated to provide a broad range of growth opportunities for the players market.

Global Cancer/Tumor Profiling Market: Segmentation

Global cancer/tumor profiling market can be segmented on the basis of application, technology, technique, and region. The application segment of the market can be divided into diagnostics, personalized medicine, prognostics, biomarker discovery, and research applications. The technology segment of the market is classified into in-situ hybridization, quantitative polymerase chain reaction, next-generation sequencing, and immunohistochemistry. The technique segment of cancer/tumor profiling market is diversified into metabolomics, genomics, epigenetics, and proteomics. Regionally, the global market is grouped into North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.

Global Cancer/Tumor Profiling Market: Regional Analysis

North America and Europe are expected to dominate the market for global cancer/tumor profiling in the coming period. The growth of these regions can be attributed to factors such as increasing prevalence of patients suffering from cancer, encouraging government plans that are concentrated toward appropriate diagnosing and screening, the existence of a huge number of technology suppliers, and accessibility of enhanced research & development. Asia Pacific region is also anticipated to boost the market in the near future owing to the better buying power of patients, increasing frequency of cancer, and economic improvements. Furthermore, the increasing need for cost-effective and safe therapeutics and diagnostics are also propelling cancer/tumor profiling market in this region.

Global Cancer/Tumor Profiling Market: Competitive Players

The key players in global cancer/tumor profiling market include Illumina Inc., HTG Molecular Diagnostic, QIAGEN N.V., Boreal Genomics, Inc., Caris Life Sciences, Genomic Health, Inc., and Life Technologies Corporation. The other prominent players in the market are Oxford Gene Technology Ltd., Nanostring Technologies, Precision Therapeutics, Inc., Ribomed Biotechnologies, Precision Therapeutics, Inc., Oncopath Laboratory, and Neogenomics Laboratories.

Global Cancer/Tumor Profiling Market: Regional Segment Analysis

  • North America
    • U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • The Middle East and Africa

What Report Provides

  • Full in-depth analysis of the parent market
  • Important changes in market dynamics
  • Segmentation details of the market
  • Former, on-going, and projected market analysis in terms of volume and value
  • Assessment of niche industry developments
  • Market share analysis
  • Key strategies of major players
  • Emerging segments and regional markets
  • Testimonials to companies in order to fortify their foothold in the market.

Table Of Content

Choose License Type

Request the coronavirus impact analysis across industries and markets

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (844) 845-5245
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #

US OFFICE NO +1 (844) 845-5245
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed